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Abstract
The objective of the research was to estimate the early and remote results of surgical treatment in patients with deep vein
thrombosis of the inferior vena cava.
Material and methods. The results of treating 790 patients with lower limb deep vein thrombosis and thrombosis of the
inferior vena cava were analyzed. Depending on treatment, all the patients were divided into the following groups: Group
IA consisted of 380 (68.5%) patients with deep vein thrombosis who underwent open complete or partial thrombectomy
with or without surgical prevention of pulmonary thromboembolism; Group IB consisted of 50 (9.0%) patients with deep vein
thrombosis who received combined treatment with surgical prevention of pulmonary thromboembolism; Group IC consisted
of 125 (22.5%) patients with transfascial thrombosis who underwent thrombectomy of the apical thrombotic masses of deep
veins followed by radical venectomy; Group II consisted of 235 (29.7%) patients with deep vein thrombosis who received
conservative anticoagulant therapy only.
For investigation of patients, there were used the following laboratory methods of examination: duplex ultrasound scanning,
X-ray phlebography, computer tomography, echocardioscopy and radionuclide phleboscintigraphy.
Results. The results of surgical and combined methods of treating deep vein thrombosis in clinical subgroups were evaluated
using a three-point scale - good, satisfactory and unsatisfactory. The cumulative analysis of the results of the postoperative
period during 3 years of follow-up showed that good and satisfactory results were observed in 89.3% of patients of Group IA,
81.7% of patients of Group IB, 88.4% of patients of Group IC, and 35.3% of patients of Group II. Three years after treatment,
the signs of chronic venous insufficiency were found in 51.6% of patients who underwent conservative treatment, 36.4% of
patients who received combined treatment, 10.2% of patients who underwent partial thrombectomy, 2.9% of patients who
received surgical treatment of transfascial thrombosis; they were absent in patients who underwent radical thrombectomy.
Conclusions. In quantitative evaluation of the early and remote results of treating deep vein thrombosis of the inferior vena
cava, a significant improvement in the patients’ condition in all parameters was observed in the main group as compared to
the control one.
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Problem statement and analysis of the
recent research
In the United States and European Union, deep vein thrombo-
sis (DVT) of the inferior vena cava (IVC) has rates of 150-300
cases per 100, 000 population per year [1, 7, 11, 14]. Thus,
according to various data, 2 to 20 million cases of DVT are
registered annually in the USA [7, 12]; in 600-700 thousand
of cases, pulmonary embolism (PE) [5, 12] occurs accounting
for 26-28% of all cases [7].
Three-five years after conservative treatment, the conse-
quences of DVT are registered in 25-87% of patients who
had extensive tibial vein thrombosis, 46% of patients who had
tibial and femoral vein thrombosis and 90-98% of patients
after iliofemoral phlebothrombosis [3, 16]. Five-ten years
after treatment, the symptoms of post-thrombotic syndrome
(PTS) are observed in 49-100% of patients [3, 18, 19], while
post-thrombotic changes in deep veins of both lower extremi-
ties are detected in 7.4-34.1% of patients, and inferior vena
cava syndrome (IVCS) - in 12.3% of patients [10].
Even the results of conservative treatment of DVT do
not convince authors of the ineffectiveness of anticoagulant
therapy - 5 years after treatment, 95% of patients are diag-
nosed with venous hypertension, 90% of patients develop
pronounced venous reflux, 50% of patients suffer from the
dysfunction of veno-muscular pump of the tibia, in 15% of
patients, trophic ulcers are found, and in 15-50% of patients
- intermittent venous claudication [15, 17]. B. Geier and
co-authors (2009) provide data on the preservation of perme-
ability of recanalized thrombosed veins 5 years after open
thrombectomy in 75% of patients, and the presence of signs
of PTS in 20% of cases only [13].
Despite the constant increase in PE incidence, the fre-
quency of surgical treatment of DVT remains low. Venous
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thrombectomy are performed in 20-25% of cases only [6, 8],
which, according to I.M. Hudz (2006), is mainly due to the
doctor’s qualification and traditions of the clinic [2].
In developed countries, among chronic veins diseases,
PTS accounts for 28% of all cases. It is diagnosed in 2-7%
of people of working age [9], 10% of whom have the signs
of disability [10]. Despite modern conservative treatment of
DVT, there is a clear tendency towards the increase in the
incidence of PTS. It occurs in 20-52.8% of patients who had
DVT [4, 7]. Trophic changes in the skin occur 4-6 years after
DVT [10].
Thus, even modern anticoagulant therapy for DVT does
not allow preventing the development of PTS in the remote
period and the results of treatment remain unsatisfactory. PT
is still considred to be one of the main causes of lethality and
the number of patients with severe forms of chronic venous
insufficiency (CVI) is steadily increasing.
The objective of the research was to estimate the early
and remote results of surgical treatment in patients with DVT
of the IVC.
1. Material and methods
The results of treating 790 patients with lower limb DVT and
thrombosis of the IVC who were treated in the department of
Surgery and Urology of the Transcarpathian Regional Clin-
ical Hospital named after A. Novak during 2006-2016 were
analyzed. The patients’ age varied from 17 to 83 years; the
average age was 46 ± 2.3 years. Among them, there were
334 (42.3%) men and 456 (57.7%) women. The majority of
patients was of working age - 735 (93.0%) people. At the
same time, about half of all examined and treated patients
were young and of middle age (under the age of 40 years)
-395 (50%) individuals.
Depending on treatment, all the patients were divided into
the following groups:
• Group I (the main group) consisted of 555 (70.3%)
patients who underwent surgical treatment of DVT and
PE prophylaxis with subsequent conservative treatment,
in particular:
– Group IA consisted of 380 (68.5%) patients with
DVT who underwent open complete or partial
thrombectomy with or without surgical prevention
of PE;
– Group IB consisted of 50 (9.0%) patients with
DVT who received combined treatment with sur-
gical prevention of PE;
– Group IC consisted of 125 (22.5%) patients with
transfascial thrombosis who underwent thrombec-
tomy of the apical thrombotic masses of deep
veins followed by radical venectomy.
• Group II (the control group) consisted of 235 (29.7%)
patients with DVT who received conservative anticoag-
ulant therapy only.
All the patients were prescribed anticoagulant, infusion
and antispasmodic, compression therapy, regardless of the
need for surgical treatment.
For investigation of patients, there were used the follow-
ing laboratory and instrumental methods of examination: du-
plex ultrasound scanning (”ULTIMA PRO-30, z.one Ultra”,
Zonare Medical Systems Inc., USA), X-ray phlebography
(DSA, Integris-2000, Philips), computer tomography (So-
matom CRX, Siemens, Germany, 1994), echocardioscopy.
Radionuclide phleboscintigraphy was performed (the emis-
sion computed tomography scanner ”Tamara”, Ukraine) as
well. There were determined the average transit time (ATT)
of the isotope and the load index (LI).
Considerable attention was given to the determination of
the type of thrombotic lesions and the nature of thrombotic
masses. Thus, in most patients of the main group (408 (73.5%)
individuals), occlusive thrombotic lesions were found; in 129
(23.2%) patients, mural thrombotic lesions were observed;
in 18 (3.3%) patients, fragmentary thrombotic lesions were
detected. In 403 (72.6%) patients of the main group, the
proximal part of thrombotic masses had a floating nature.
Among the patients of the control group, occlusive thrombotic
lesions were found in 162 (68.9%) patients, mural thrombotic
lesions were seen in 73 (31.1%) patients; the floating apex of
thrombotic masses was observed in 34 (14.5%) cases. Patients
with fragmentary thrombotic lesions were not included in the
control group.
By the nature of thrombotic masses, there were distin-
guished loose, well-formed and tumor thrombi. Loose throm-
botic masses were detected in 417 (52.8%) patients, well-
formed thrombotic masses were observed in 344 (43.5%)
patients, tumor thrombotic masses were found in 29 (3.7%) pa-
tients. In patients of the main group, loose thrombotic masses
were detected in 380 (68.5%) cases, well-formed thrombotic
masses were observed in 146 (26.3%) cases and tumor throm-
botic masses were found in 29 (5.2%) cases. In the control
group, well-formed thrombotic masses were found in 198
(84.3%) patients, loose thrombotic masses were detected in
37 (15.7%) patients. Patients with tumor thrombosis were
not included in the control group as they do not respond to
anticoagulation therapy.
Surgical interventions aimed at DVT treatment and PE
prevention are presented in Table 1, 2, 3.
2. Results and discussion
The results of surgical and combined methods of treating DVT
in clinical subgroups were evaluated using a three-point scale
- good, satisfactory and unsatisfactory.
The criteria for good results after surgical and combined
treatment of DVT were considered the intraoperative restora-
tion of occluded arterial inflow and outflow, venous collec-
tor, confirmed by ultrasound; increase in linear (LFR) and
volumetric (VFR) blood flow rate (VFR) above the site of
occlusion by more than 50% during ultrasound; complete
restoration of the function the affected limb; the absence of
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Table 1. Surgical intervention for DVT in patients of Group IA
Type of surgical intervention Number
Thrombectomy from the PV and calf sinuses, ligation of calf sinuses at the site of entry into the PV 70 (18.4%)
Thrombectomy from the PV, ligation of thrombosed trunks of the tibial veins at the site of entry into the PV 35 (9.2%)
Thrombectomy from the SFV, ligation of the SFV below the DFV 67 (17.6%)
Thrombectomy from the CFV, ligation of the SFV below the DFV 55 (14.5%)
Thrombectomy from the CFV, ligation of the DFV at the site of entry into the CFV 21 (5.5%)
Thrombectomy from the CFV and the EIV, ligation of the SFV below the DFV 58 (15.3%)
Thrombectomy from the CFV and the EIV, ligation of the CFV below the GSV 3 (0.8%)
Thrombectomy from the CFV and the EIV with the formation of distal AV fistula 13 (3.4%)
Thrombectomy from the EIV and the CIV, ligation of the EIV below the IIV 7 (1.8%)
Thrombectomy from the infra- and/or intrarenal portions of the IVC 11 (2.9%)
Thrombectomy from the infra- and/or intrarenal portions of the IVC + surgical caval plication of the IVC 5 (1.3%)
Thrombectomy from the suprarenal portion of the IVC 9 (2.4%)
Thrombectomy from the suprarenal portion of the IVC + caval plication of the IVC 12 (3.2%)
Thrombectomy from the subdiaphragmatic portion of the IVC and the right auricle 1 (0.3%)
Thrombectomy from the subdiaphragmatic portion of the IVC and the right auricle + surgical caval plication
of the IVC
13 (3.4%)
Total 380 (100%)
Notes: PV – popliteal vein, DFV – deep femoral vein, SFV- superficial femoral vein, CFV – common femoral vein, EIV– exterrnal illiac vein,
IIV – internal illiac vein, CIV – common illiac vein, GSV - great saphenous vein, AV fistula - arteriovenous fistula.
Table 2. Combined treatment of patients in Group IB
Apex of thrombotic masses
Combined treatment Calf veins Popoliteal veins Femoral veins Illiac veins Total
Regional
throm-
bolytic
Vena cava filter im-
plantation
3
7
2
5
7
19
19
19
31
50
therapy Surgical thrombec-
tomy
4 3 12 - 19
Table 3. Surgical interventions in Group IC
Surgical intervention Number
Partially open CFV thrombectomy, crossectomy, phlebectomy 54 (43.2%)
Open CFV thrombectomy (CFV venectomy), crossectomy, phlebectomy 8 (6.4%)
Partially open PV thrombectomy, crossectomy, phlebectomy of the SSV and /or the GSV 15 (12.0%)
Open PV thrombectomy (PV venectomy), crossectomy, phlebectomy of the SSV and the GSV 5 (4.0%)
Open PV and/or calf sinuses thrombectomy (PV venectomy), crossectomy, phlebectomy of the SSV and the
GSV, ligation of the thrombus in calf sinuses
26 (20.8%)
Ligation of the SFV below the DFV, crossectomy, phlebectomy 3 (2.4%)
Crossectomy, phlebectomy of the GSV, ligation of the PV below the SSV 7 (5.6%)
Open venae perforantes thrombectomy, crossectomy, phlebectomy 7 (5.6%)
Total 125 (100%)
Notes: SSV – small saphenous vein.
”bursting” pain in the affected lower limb; the reduction in
limb edema by not less than 50% as compared to preoperative
indices and its complete disappearance after a night’s sleep;
the absence of DVT/PE relapses and trophic changes.
The results were considered satisfactory in case of the
intraoperative restoration of the occluded venous trunk and
venous collector, confirmed by ultrasound; the increase in
LFR and VFR within 30-50% during ultrasound; moderate
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limitation in the function of the affected limb; considerable
reduction in feeling of ”bursting” pain in the affected lower
limb; the reduction in limb edema within 50% in comparison
with preoperative indices; the absence of DVT/PE recurrence;
the presence of hyperpigmentation and skin induration.
The results were considered unsatisfactory in case of
rethrombosis of the occluded venous trunk and venous collec-
tor confirmed by ultrasound; the decrease in LFR and VFR
as compared to preoperative indices during ultrasound; sig-
nificant impairment of the function of the affected limb; the
preservation or progression of feeling of ”bursting” pain in the
affected lower limb; the increase in or the presence of limb
edema, especially in the evening, and the absence of reduction
in limb edema after a night’s sleep; the presence of DVT/PE
recurrence; expressed signs of trophic changes in the skin of
the shin of the affected limb in the form of trophic ulcers.
In case of graduated exersice, the dynamics of venous
outflow before and after treatment and in the long-term period
(up to 3 years) showed the effectiveness of surgical interven-
tion, both radical and palliative one. The reduction in the
obstruction of large venous collectors in partial thrombectomy
leads to the significant increase in volumetric blood flow, and
complete thrombectomy restores it to normal. Thus, the ATT
in the veno-muscular pump of the tibia decreased from 21-36
sec to 7-12 sec (complete thrombectomy) and to 11-18 sec
in partial thrombectomy. LFR increased from 2-5 cm/sec to
9-18 cm/sec and to 4-9 cm/sec, respectively. The LI increased
from 1-1.2 to 2.8-3.4 and to 2.2-2.8, respectively.
At the same time, in the group of patients who received
conservative therapy only, the ATT after treatment was 18-26
sec, LFR - 2-6 cm/sec, the LI - 1-1.3. The results of blood
flow restoration after combined treatment are the following:
the ATT - 9-14 sec, the LI - 2.3-3.0 and LFR - 7-11 cm/sec.
The average indices of the ATT, the LI and LFR before and
after treatment were used for statistical processing.
The data obtained when studying blood flow were consis-
tent with the clinical results that considered the prevalence of
CVI signs in patients of both groups in the long-term period
after DVT. The complaints were reported in 51.6% of patients
who underwent conservative treatment, 36.4% of patients who
received combined treatment, 10.2% of patients who under-
went partial thrombectomy, 2.9% of patients who received
surgical treatment of transfascial thrombosis; they were absent
in patients who underwent radical thrombectomy. Thus, the
functional results of surgical treatment exceeded the results
of the conservative one.
Prior to the discharge from the hospital, in 84 (21.1%) out
of 380 patients of Group IA, the results of surgical treatment
of DVT of the IVC were evaluated as good; in 292 (76.8%) pa-
tients, they were evaluated as satisfactory and only in 4 (1.1%)
patients, the results of surgical treatment were unsatisfactory.
The complications were observed in 38 (10%) patients.
The most frequent complication was lymphorrhea, which
was observed in 21 (4.7%) of 380 patients. The average
duration of lymphorrhea was 12±1.4 days (11 to 22 days). To
eliminate lymphorrhea, phlebotrophic drugs, tight bandaging
of the postoperative wound zone, and, if necessary, ultrasound-
guided seroma drainage were used.
Marginal necrosis of the postoperative wound was ob-
served in 6 (1.4%) of 380 patients, in particular at the femoral
and popliteal access sites - in 4 and 2 patients, respectively.
The effects of necrotic changes in all patients were eliminated
using local therapy and the postoperative wounds at the site
of marginal necrosis healed by secondary intention.
The suppuration of the postoperative wound was observed
in 4 (0.9%) out of 380 patients. The suppuration of the post-
operative wound in the inguinal region was observed in 2
patients; the suppuration of the postoperative wound in the
popliteal region was found in 1 patient; the suppuration of the
postoperative wound after laparotomy was seen in 1 patient. In
all the patients, inflammatory complications were superficial
and did not spread below the surficial fascia. The manifes-
tations of purulent inflammation were eliminated within 2
weeks after the administration of local antibiotic therapy and
drainage in addition to systemic therapy. The postoperative
wounds healed by secondary intention.
In 1 (0.2%) out of 380 patients, there was onbserved bleed-
ing from the postoperative wound in the inguinal region. The
latter was due to diffuse bleeding from the subcutaneous
cellular tissue on the background of anticoagulant therapy
that required repeated surgical intervention with thorough
haemostasis.
In 4 (0.9%) out of 380 patients, the spread of the throm-
botic process beyond the surgical site was observed - 2 patients
with open CFV thrombectomy and ligation of the SFV below
the DFV and 2 patients after open PV thrombectomy and
ligation of calf sinuses. The extension of thrombotic lesions
in the proximal direction in the postoperative period was ob-
served in adequate anticoagulant therapy. In 2 patients, during
the examination, the signs of hereditary thrombophilia were
detected; 1 patient was diagnosed with oncological pathol-
ogy; in one patient, the cause of rethrombosis was not found.
All patients with thrombosis relapse underwent conservative
anticoagulant therapy which allowed to prevent PE in all the
patients.
After surgical caval plication of the IVC, none of 30 pa-
tients had signs of PE before their discharge from the hospital.
In 2 (3.9%) out of 51 patients, up to 5 days after laparo-
tomy for the thrombotic occlusion of the IVC, there was
observed the phenomenon of intestinal paresis which was
eliminated using conservative agents.
The length of patients’ stay in the hospital after open
thrombectomy ranged from 10 to 23 days, on average 14 ±
2.3 days. There were no lethal cases as well as cases of PE.
There were studied the results of surgery for DVT and PE
prevention in 246 patients of Group IA in the early postopera-
tive period during the 1st year of follow-up. In 134 (54.5%)
out of 246 patients, the results of surgical treatment were eval-
uated as good; in 107 (43.5%) patients, they were evaluated
as satisfactory and only in 5 (2.0%) patients, the results of
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surgical treatment were unsatisfactory.
In 217 patients after partial thrombectomy for deep veins
of the lower extremities in the period from 2 to 4 months,
ligature resorption was observed. The ligation was applied
with the aim of preventing PE, with the restoration of the
permeability of the venous trunk. By the time of ligature
resorption in the distal regions, subtotal recanalization (to
60-80%) was usually observed.
The complications in the early postoperative period were
detected in 6 (2.4%) out of 246 patients of Group IA. In 5
patients, the reccurence of DVT with the extension of the
process in the proximal direction was observed. In 2 patients,
the relapse was caused by oncologic pathology, in 2 patients,
it was due to diabetes mellitus. In one patient, the cause
of DVT reccurence was not detected. All the patients were
prescribed anticoagulant therapy. In cases of oncological
disease, lifelong anticoagulation was recommended.
In one patient, after surgical caval plication, embolism
at the site of plication was observed. At the same time, the
thrombotic lesion did not spread beyond the zone of caval
plication and no signs of PE were observed. Anticoagulant
therapy for this patient was extended to 12 months.
In all the patients who underwent the placement of AV
fistula after thrombectomy from the femoral-illiac segment,
the fistulas were closed independently within 3-10 weeks.
There were observed no signs of thrombosis relapse, purulent-
septic complications and general complications. PTFE coated
ligature was removed after ultrasound confirmation of closure
of the AV fistula.
According to instrumental study, if the diameter of fistula
was up to 4 mm, there were no signs of the right heart overload
and ”stealing” blood from the peripheral arterial bed.
There were observed 30 patients after surgical caval pli-
cation in the early postoperative period. In dynamic control,
it was found that in 27 (90%) of 30 patients 10 to 12 months
after operation, the clips on the IVC became visible with grad-
ually restoration of its lumen. In 3 patients, the lumen of the
IVC restored within next 6 months (up to 18 months after
surgery).
To determine the individual indices of regional and central
hemodynamics in patients of Group IA after caval plication,
echocardiography and ultrasound were performed in the pre-
operative and postoperative periods. Surgical caval plication
after thrombectomy of the IVC was found not to affect the
venous return to the heart.
In the early postoperative period, the signs of CVI were
observed in 5 (2.0%) out of 246 patients of Group IA. In the
early postoperative period, there were no fatal cases as well
as PE cases.
There were studied the results of surgery for DVT and
PE prevention in 203 patients of Group IA in the remote
postoperative period within 3 years. In 149 (73.4%) out of
203 patients, the results of surgical treatment of DVT of of
the IVC were evaluated as good, in 39 (19.2%) patients, they
were evaluated as satisfactory and only in 15 (7.4%) patients,
they were unsatisfactory.
In 7 (3.4%) patients, the reccurence of DVT was observed.
In 1 patient, it was caused by a long journey; in 6 patients, its
causes were not found. Within 6 months after anticoagulation
therapy, in all 7 patients, the signs of subtotal (n=5) and total
(n=2) recanalization were seen.
In 17 (8.4%) patients, the signs of CVI in the remote
period were observed. At the same time, in the remote postop-
erative period, according to ultrasound, the indices of regional
and central hemodynamics did not differ from normal val-
ues. No fatal case and PE signs were observed in the remote
period.
The cumulative analysis of the results of the postoperative
period during 3 years of follow-up showed that good and sat-
isfactory results of surgical treatment of DVT were observed
in 89.3% of patients.
Prior to the discharge from the hospital, in 38 (76.0%) out
of 50 patients of Group IB, the results of surgical treatment
of DVT of the IVC were evaluated as good; in 12 (24.0%)
patients, they were evaluated as satisfactory. In 4 (8.0%)
out of 50 patients, there were observed local and general
complications.
In 2 patients, after open thrombectomy from the CFV
and intraoperative regional thrombolytic therapy, there was
observed postoperative lymphorrhea in the inguinal region
which stopped independently in 11 and 15 days, respectively.
In one patient, there was found marginal necrosis of the post-
operative wound in the inguinal region. In one patient, within
4 days after regional thrombolytic therapy and vena cava filter
implantation, there were observed short-time local bleeding
and small subcutaneous hematomas in the area of injections,
that were eliminated through longer compression of injection
sites.
After regional thrombolytic therapy, the total (90-100%)
recanalization of affected venous segments was observed in
43 patients; subtotal (70-85%) recanalization was found in 5
patients; partial (35-50%) recanalization of affected venous
segments was detected in 2 patients.
The duration of patients’ stay at the hospital after com-
bined treatment of thrombosis of the IVC ranged from 12 to
16 days, on average 13± 1.3 days. There were no lethal cases
as well as cases of PE.
Twelve months after combined treatment, the results of
treatment were evaluated in 46 patients of Group IB, 30 pa-
tients after vena cava filter implantation and regional throm-
bolytic therapy and 16 patients after thrombectomy and intra-
operative regional thrombolytic therapy in particular. In 36
(78.3%) out of 46 patients, the results of combined treatment
of DVT of the IVC were evaluated as good; in 6 (13.0%) pa-
tients, they were evaluated as satisfactory; in 4 (8.7%) patients,
they were unsatisfactory. The complications were observed in
7 (15.2%) out of 46 patients.
In 30 patients with permanent vena cava filter, its status
had been monitored by the end of the 1st year of observation.
Vena cava filter migration was detected in 3 patients in the
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early postoperative period - 2 patients after the implantation
of vena cava filter ”Greenfield” and 1 patient after the im-
plantation of vena cava filter ”Reptela”. In 2 patients, vena
cava filter migration into the left CIV occurred; in 1 patient,
vena cava filter migration in the proximal direction into the
suprarenal portion of the IVC was observed. During proximal
vena cava filter migration, massive fatal PE was observed.
In one patient, thrombotic masses were observed, which,
however, did not result in PE. In 2 patients, the signs of lum-
bar pain syndrome were found 2.5 and 3 months after the
implantation of vena cava filter, respectively.
In 7 patients with subtotal or partial recanalization before
their discharge from the hospital, total recanalization occurred
in the early postoperative period - up to 6 months of follow-up.
In one patient, reccurent thrombosis was observed after
open thrombectomy from the SFV and intraoperative regional
thrombolytic therapy. Its manifestations were eliminated con-
servatively. During the 1st year of observations, there were no
cases of PE in 16 patients after open thrombectomy combined
with regional thrombolytic therapy. There were no fatal cases.
In the early postoperative period, CVI symptoms were
observed in 2 (4.3%) of 46 patients of Group IB.
Thirty-six months after combined treatment, the results
of treatment were evaluated in 11 patients of Group IB - 4
patients after vena cava filter implantation and regional throm-
bolytic therapy and 7 patients after thrombectomy and intra-
operative regional thrombolytic therapy. In 4 (36.4%) out of
11 patients, the results of combined treatment of DVT of the
IVC were evaluated as good; in 2 (18.2%), the results were
assessed as satisfactory; in 5 (45.4%) patients, the results of
combined treatment in the remote postoperative period were
unsatisfactory. In 5 (45.4%) out of 11 patients, the complica-
tions were observed.
Migration of permanent vena cava filter ”Osot” into the
left CIV was detected in one patient in the remote postoper-
ative period. However, it did not result in blood flow distur-
bance. In 2 patients, proximal vena cava filter migration and
PE were observed. Both cases were fatal.
In 2 patients, reccurent thrombosis was observed after
open thrombectomy from the PV and regional thrombolytic
therapy. Its manifestations were eliminated conservatively.
During the 1st year of observations, there were no cases of PE
in 7 patients after open thrombectomy combined with regional
thrombolytic therapy. There were no fatal cases.
In 3 (27.3%) patients, the signs of CVI were observed in
the remote postoperative period.
According to the cumulative analysis, after combined treat-
ment, good and satisfactory results in the remote postoperative
period were achieved in 81.7% of patients.
Prior to the discharge from the hospital, in 114 (91.2%)
out of 125 patients of Group IC, the results of surgical treat-
ment of transfascial thrombosis were evaluated as good, in
8 (6.4%) patients, they were evaluated as satisfactory; in 3
(2.4%) patients. surgical treatment was unsatisfactory. The
complications were observed in 10 (8.0%) out of 125 patients
operated on for transfascial thrombosis.
The most frequent complication was lymphorrhea, which
was observed in 4 (3.2%) out of 125 patients including one
patient with seroma formation. The average duration of lym-
phorrhea was 12±1.4 days (10 to 23 days).
In 3 (2.4%) patients, there was found marginal necrosis
of the postoperative wound in the inguinal region. In all
patients, the effects of necrotic changes were eliminated using
local therapy, the postoperative wounds at the site of marginal
necrosis healed by secondary intention.
Reccurent thrombotic process in the immediate postoper-
ative period was observed in 3 (2.4%) patients. Considering
the fixed nature of the proximal portion of thrombotic masses,
it was decided to continue conservative anticoagulant therapy.
The duration of patients’ stay at the hospital after surgical
treatment of transfascial thrombosis ranged from 10 to 14
days, on average 11 ± 1.2 days. There were no fatal cases as
well as cases of PE.
The results of treatment of transfascial thrombosis in the
early postoperative period up to 1 year were evaluated in 71
patients of Group IC up. In 68 (95.8%) patients, the results
of surgical treatment were evaluated as good; in 2 (2.8%) pa-
tients, they were evaluated as satisfactory; in 1 (1.4%) patient,
the results of surgical treatment were unsatisfactory. In the
early postoperative period, the complications were observed
in 2 (2.8%) patients.
Recurrence of the thrombotic process in the early postop-
erative period was observed in 1 (1.4%) patient as a result of
self-cessation of anticoagulant therapy. Considering the fixed
nature of the proximal portion of the thrombotic masses, it
was decided to continue conservative anticoagulant therapy.
In one patient, 7 months after radical phlebectomy and
thrombectomy from the the GSV, acute myocardial infarction
occurred. The patient underwent X-ray contrast coronaro-
ventriculography and coronary artery stenting. After 3 days,
the patient was discharged to an outpatient program in a satis-
factory condition.
There were no cases of PE or fatal cases during the ob-
servation in the early postoperative period. In 1 (1.4%) of 71
patients of Group IC, the signs of CVI were observed in the
early postoperative period.
The remote results of surgical treatment of transfascial
thrombosis were evaluated in 34 patients of the main group.
In 31 (91.2%) patients, the results of surgical treatment of
transfascial thrombosis were evaluated as good, in 2 (5.9%)
patients, the results were evaluated as satisfactory; in 1 (2.9%)
patient, they were unsatisfactory.
Recurrence of the thrombotic process in the tibial-popliteal
segment was observed in one (2.9%) patient on the third year
of follow-up. At the same time, the apex of thrombotic masses
was fixed. The cause of recurrent thrombotic lesions was not
found. The patient was prescribed anticoagulant therapy. In
the remote postoperative period, there were no cases of PE or
fatal cases.
In the remote postoperative period, the signs of CVI were
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detected in 2 (5.9%) patients of Groups IC.
According to the cumulative analysis, good and satisfac-
tory results of surgical treatment of transfascial thrombosis
were observed in 88.4% of patients at the end of the third year
of follow-up.
Prior to discharge from the hospital, in 7 (3.0%) of 235
patients of Group II, PE was observed on the background of
anticoagulant therapy; 2 patients died. In 4 out of 5 patients
who had an episode of nonfatal PE, there were observed the
signs of disability during the next year of follow-up. Bleeding
of varying intensity (blood in the urine (n=4), bleeding while
teeth brushing (n=5), prolonged and heavy menstrual bleeding
(n=4) and bleeding at the injection site (n = 9), post-injection
hematomas (n=2)) was observed in 24 patients on the back-
groung of taking anticoagulants in the period up to 1 month;
in all cases, it was stopped conservatively.
The results of conservative treatment during 12 months
of observation were evaluated in 164 patients of Group II.
Thus, good results of conservative therapy were found in 38
(23.2%) patients; in 71 (43.3%) patients, the results were satis-
factory; in 55 (33.5%) patients, the results were unsatisfactory.
Within 12 months of observation, reccurent thrombosis was
found in 27 (16.7%) patients: 11 patients developed it on the
background of conservative treatment; 16 patients developed
thrombosis after conservative treatment cessation, 6 months
after anticoagulation therapy. In 3 patients, on the background
of reccurent thrombosis, the signs of PE were detected; one
case of thromboembolism was fatal. In 2 patients who man-
aged to save their life after PE, there were observed symptoms
of disability.
By the end of the first year of follow-up, in 36 (22.0%) pa-
tients of the control group, significant clinical manifestations
of CVI were found; in 7 (19.4%) patients trophic ulcers were
observed. In the period up to one year, bleeding of varying
intensity (blood in the urine (n=2), bleeding while teeth brush-
ing (n=3), prolonged and heavy menstrual bleeding (n=2) and
post-injection hematomas (n=1)) was observed in 8 (4.9%)
patients on the background of anticoagulant therapy; in all
cases, bleeding was stopped conservatively.
At the end of the 3rd year of observation, good results
of conservative therapy were found in 9 (8.7%) patients; in
41 (39.4%) patients, they were satisfactory; in 54 (51.9%)
patients, the results were unsatisfactory. By the end of the
3rd year of observation, reccurent thrombosis was detected
in 7 (6.7%) patients. In 3 patients with reccurent thrombosis,
the signs of PE were observed; one case of thromboembolism
was fatal. In 1 patient out of 2, who managed to save their life
after PE, there were observed symptoms of disability.
At the end of the 3rd year of follow-up, in 53 (51.0%)
patients of Group II the signs of CVI were observed. 12
(22.6%) out of 53 patients of Group II developed trophic
ulcers.
At the end of the 3rd year of observation, according to the
cumulative analysis, good and satisfactory results of conser-
vative treatment of DVT were observed in 35.3% of patients.
Thus, when comparing treatment results in the main and
control groups, a significant improvement in the patients’ con-
dition in all parameters was observed in the main group. The
early and long-term results obtained convincingly demon-
strated high efficiency and expediency of using surgical treat-
ment of DVT in comparison with isolated conservative treat-
ment. In addition, surgical restoration of the venous lumen
allows preserving the valvular apparatus of veins, preventing
the development of PTS with the subsequent CVI occurrence,
improving the results of treating patients with DVT signifi-
cantly. Moreover, surgical methods of treating DVT of the
lower extremities effectively prevent PE.
3. Conclusions
1. According to the cumulative analysis, surgical treat-
ment of DVT of the lower extremities allowed us to
achieve a positive result of treatment in 89.3% of pa-
tients, and conservative treatment of DVT of the lower
extremities allowed us to achieve a positive result of
treatment in 35.3% of patients only.
2. During 3 years of observation, the signs of CVI were
observed in 51.0% of patients of the control group and
only 8.4% of patients of the main group.
3. In quantitative evaluation of disease severity in groups
of patients depending on the method of treatment, a
significant improvement in the patients’ condition in
all parameters was observed in the main group as com-
pared to the control one.
4. Prospects for further research
The development of minimally invasive methods for surgical
treatment of DVT and prevention of PE with the aim of reduc-
ing the frequency of complications in the postoperative period
is promising.
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